Haemonetics Automated Cell Processor ACP™ 215

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

Transmedic Pte Ltd

Class:

Class C medical device

Manufactured by:

Haemonetics Corporation

Therapeutic area:

Hematology

Therapeutic indications:

The ACP 215 system can perform the following types of procedures: •Prepare collected red blood cell products with glycerol for freezing. •Deglycerolize thawed red blood cell products, removing extra cellular components, and re-suspend the red blood cells in an additive solution. •Wash red blood cell units stored in commonly used AC and additive solutions to remove plasma and extra cellular components. The ability to process-control the addition and removal of cryroprotectant solution as well as wash banked blood in a closed system significantly improves the safety and availability of blood products.

Product summary:

Models: ACP215 - 02215-220-E, RBC De-Glycerol. Sets 325mL BMB - 00236-00, RBC De-Glycerol. / Cell Wash Sets - 00235-00/235, RBC Glycerolization Sets - 00225-00/225, Additive Solution Formula 3 (AS-3), 300 mL - 0462A-00, Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M1), Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M2), Glucose 0.2% Sodium Chloride 0.9% 2000 ml - TMIS0220GOO (SOL.FIS.2000M)

Authorization date:

2010-07-28